Despite beating on the top and bottom lines, tariff uncertainty makes the outlook for ISRG stock fluid; investors may want to wait for clarity before jumping in
Intuitive Surgical's price target was cut to $590 on tariff concerns, but analysts remain positive on strong growth, new product cycle, and solid balance sheet.
Risk-on sentiment dominated Wall Street on Wednesday, as upbeat earnings reports and conciliatory messages from the Trump administration helped lift investor confidence.
Medical device company Merit Medical Systems (NASDAQ:MMSI)
will be announcing earnings results tomorrow after the bell. Here’s what investors should know.
Intuitive said it now expects full-year 2025 gross margins between 65% and 66.5%, with the tariff impact projected to grow each quarter through the end of the year.
After the closing bell on Tuesday, let's take a glimpse of the US markets and explore the top S&P500 gainers and losers in today's after-hours session.
Medical technology company Intuitive Surgical (NASDAQ:ISRG) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 19.2% year on year to $2.25 billion. Its non-GAAP profit of $1.81 per share was 4.4% above analysts’ consensus estimates.
